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Background:  The outcomes of significant tricuspid regurgitation (TR) and indications of tricuspid annuloplasty (TAP) in patients with atrial 
septal defect (ASD) have yet to be investigated. 
methods:  A total of 223 consecutive adult patients (mean age, 50 years; 51 males) who showed a significant (moderate or severe) TR 
before ASD closure were retrospectively enrolled, and their clinical and echocardiographic characteristics were reviewed. Surgical and 
transcatheter ASD closures were performed in 193 and 30 patients respectively. Among the surgical closure group, 152 and 40 patients 
underwent TAP and the Maze operation respectively. The primary endpoint was a combination of any cause of death, stroke, and heart 
failure. The secondary endpoint was a remnant of significant TR in 1 year after ASD closure.
results:  In 1 year after ASD closure, TR jet areas decreased significantly compared to those before closures in both groups of patients 
with and without TAP (13.0 ± 5.0 vs 1.5±2.7 with TAP group; 10.3 ± 2.5 vs 4.8 ± 4.5 without TAP group; before vs 1 year after TR jet area 
[cm2], both p <0.001), but 34 patients (15.3%) showed a remnant of significant TR in 1 year after closures. The age (HR = 1.04; 95% CI 
= 1.02 - 1.08; p=0.003) and TAP (HR = 0.15; 95% CI = 0.07 - 0.33; p<0.001) were associated with the remnant of significant TR after 1 
year. During a median follow-up after ASD closure for 4.0 years, 35 adverse events occurred. By multivariate Cox regression analysis, 
only the ratio of early diastolic mitral inflow velocity to mitral annuls velocity (HR = 1.07; 95% CI = 1.03 - 1.13; p=0.002) was independently 
associated with adverse events. 
Conclusion:  A significant TR may decrease after ASD closure without TAP, but a combined TAP helps to prevent remnant of TR. Although 
this study does not prove a clinical benefit of TAP in our patient population, further prospective studies involving larger number of patients 
would be necessary.
